A Study of GC101 TIL in Advanced Solid Tumors (TR)

Clinical trial NCT04967833 · RECRUITING

Trial details

NCT number: NCT04967833
Sponsor: Shanghai Juncell Therapeutics
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2021-04-22
Primary completion: 2027-12-22
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.